John Hester
Stock Analyst at Bell Potter
(4.08)
# 1,690
Out of 4,792 analysts
223
Total ratings
50%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: EIQ Echo IQ Limited | Reiterated: Hold | $1.75 | $0.57 | +208.64% | 3 | Aug 31, 2026 | |
| ASX: 4DX 4DMedical Limited | Reiterated: Buy | $6.00 | $3.49 | +71.92% | 14 | Aug 30, 2026 | |
| ASX: MSB Mesoblast Limited | Reiterated: Buy | $4.45 | $2.18 | +104.13% | 21 | Aug 28, 2026 | |
| ASX: PNV PolyNovo Limited | Upgraded: Buy | $1.00 → $1.22 | $1.00 | +22.61% | 13 | Aug 28, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Upgraded: Buy | $3.00 | $2.66 | +12.99% | 6 | Aug 28, 2026 | |
| ASX: PGC Paragon Care Limited | Reiterated: Hold | $0.17 → $0.16 | $0.14 | +18.52% | 18 | Aug 27, 2026 | |
| ASX: NAN Nanosonics Limited | Reiterated: Hold | $3.60 → $3.20 | $2.75 | +16.36% | 17 | Aug 26, 2026 | |
| ASX: CYC Cyclopharm Limited | Reiterated: Buy | $1.00 | $0.50 | +100.00% | 15 | Aug 25, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $19.00 | $16.68 | +13.91% | 33 | Aug 20, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Buy | $226.00 | $165.60 | +36.48% | 16 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.24 → $0.22 | $0.13 | +69.23% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13.00 | $11.56 | +12.46% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.50 → $6.40 | $2.25 | +184.44% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.45 → $0.42 | $0.29 | +47.37% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.09 | $0.54 | +101.85% | 7 | Jul 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.25 | $0.06 | +323.73% | 7 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.05 → $0.06 | $0.01 | +566.67% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.02 | n/a | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.00 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.91 → $3.88 | $4.39 | n/a | 3 | Nov 25, 2022 |
Echo IQ Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $1.75
Current: $0.57
Upside: +208.64%
4DMedical Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $6.00
Current: $3.49
Upside: +71.92%
Mesoblast Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $4.45
Current: $2.18
Upside: +104.13%
PolyNovo Limited
Aug 28, 2026
Upgraded: Buy
Price Target: $1.00 → $1.22
Current: $1.00
Upside: +22.61%
Sigma Healthcare Limited
Aug 28, 2026
Upgraded: Buy
Price Target: $3.00
Current: $2.66
Upside: +12.99%
Paragon Care Limited
Aug 27, 2026
Reiterated: Hold
Price Target: $0.17 → $0.16
Current: $0.14
Upside: +18.52%
Nanosonics Limited
Aug 26, 2026
Reiterated: Hold
Price Target: $3.60 → $3.20
Current: $2.75
Upside: +16.36%
Cyclopharm Limited
Aug 25, 2026
Reiterated: Buy
Price Target: $1.00
Current: $0.50
Upside: +100.00%
Telix Pharmaceuticals Limited
Aug 20, 2026
Reiterated: Buy
Price Target: $19.00
Current: $16.68
Upside: +13.91%
Pro Medicus Limited
Aug 19, 2026
Reiterated: Buy
Price Target: $226.00
Current: $165.60
Upside: +36.48%
Aug 18, 2026
Reiterated: Buy
Price Target: $0.24 → $0.22
Current: $0.13
Upside: +69.23%
Aug 12, 2026
Downgraded: Hold
Price Target: $13.00
Current: $11.56
Upside: +12.46%
Aug 10, 2026
Reiterated: Buy
Price Target: $6.50 → $6.40
Current: $2.25
Upside: +184.44%
Aug 3, 2026
Reiterated: Buy
Price Target: $0.45 → $0.42
Current: $0.29
Upside: +47.37%
Jul 12, 2026
Reiterated: Buy
Price Target: $1.09
Current: $0.54
Upside: +101.85%
May 28, 2026
Reiterated: Buy
Price Target: $0.25
Current: $0.06
Upside: +323.73%
Dec 17, 2025
Reiterated: Buy
Price Target: $0.05 → $0.06
Current: $0.01
Upside: +566.67%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.02
Upside: n/a
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.00
Upside: n/a
Nov 25, 2022
Reiterated: Hold
Price Target: $4.91 → $3.88
Current: $4.39
Upside: n/a